Cytosolic delivery of antisense oligonucleotides by listeriolysin O-containing liposomes
- 16 June 2003
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 10 (13) , 1105-1115
- https://doi.org/10.1038/sj.gt.3301966
Abstract
Antisense oligodeoxynucleotides (ODNs) possess great potential as sequence-specific therapeutic agents. Sufficient concentrations of intact ODN must bypass membrane barriers and access the cytosol and nucleus, for ODNs to be therapeutically effective. A cytosolic delivery strategy was designed to improve the efficiency of ODN delivery in bone-marrow-derived macrophages. This liposome-based formulation utilizes listeriolysin O (LLO), the endosomolytic hemolysin from Listeria monocytogenes, to mediate the escape of ODN from endocytic compartments into the cytosol. To monitor the cytosolic delivery of ODN, subcellular trafficking of fluorescently labeled ODNs was visualized using epifluorescence microscopy. The expression of target protein and mRNA after delivery was measured using flow cytometry and Northern blot analysis, respectively. ODN specific for murine intercellular adhesion molecule-1 (ICAM-1) encapsulated in LLO-liposomes was released to the cytosol and trafficked to the nucleus, efficiently and specifically suppressing activation-induced expression of ICAM-1 at both protein and mRNA levels. Delivery without LLO resulted in sequestration of ODN in vesicular compartments leading to little inhibition of ICAM-1 expression, which supports the requirement of LLO for efficient cytosolic delivery using this system. The data clearly demonstrate that LLO-mediated escape of ODN from intracellular vesicles is an effective approach to achieve full therapeutic antisense activity in cultured macrophages.Keywords
This publication has 35 references indexed in Scilit:
- Antisense Oligonucleotides: Promise and RealityAnnual Review of Pharmacology and Toxicology, 2001
- Correlation of Toxicity and Pharmacokinetic Properties of a Phosphorothioate Oligonucleotide Designed to Inhibit ICAM-1Toxicologic Pathology, 1999
- PROTECTION AGAINST ALLOGRAFT REJECTION WITH INTERCELLULAR ADHESION MOLECULE-1 ANTISENSE OLIGODEOXYNUCLEOTIDES1Transplantation, 1998
- Evaluation of the Toxicity of ISIS 2302, a Phosphorothioate Oligonucleotide, in a 4-Week Study in CD-1 MiceAntisense and Nucleic Acid Drug Development, 1997
- Development of Targeted Delivery Systems for Nucleic Acid DrugsJournal of Drug Targeting, 1997
- Role of the intercellular adhesion molecule-1(ICAM-1) in endotoxin-induced pneumonia evaluated using ICAM-1 antisense oligonucleotides, anti-ICAM-1 monoclonal antibodies, and ICAM-1 mutant mice.Journal of Clinical Investigation, 1996
- Cationic Lipid Is Not Required for Uptake and Selective Inhibitory Activity of ICAM-1 Phosphorothioate Antisense Oligonucleotides in KeratinocytesJournal of Investigative Dermatology, 1994
- INHIBITION OF TRANSPLANT REJECTION BY PRETREATMENT OF XENOGENEIC PANCREATIC ISLET CELLS WITH ANTI-ICAM-1 ANTIBODIESTransplantation, 1994
- Adhesion receptors of the immune systemNature, 1990
- pH‐sensitive liposomes mediate cytoplasmic delivery of encapsulated macromoleculesFEBS Letters, 1985